Biogen
Neurology & CNS Therapeutics · Prescription Drugs

Biogen: Funding & valuation

Biogen has $1M paid in by investors, lenders and donors.

Financials

Revenue of $9.9B in 2025. +2.2% on the year before. Net income $1.3B.

$9.9BRevenue2025 · +2.2%
$1.3BNet income2025 · −20.8%
Revenue by yearas filed, with the net income
2025$9.9Bnet income $1.3B
2024$9.7Bnet income $1.6B
2023$9.8Bnet income $1.2B
2022$10.2Bnet income $3B
2021$11Bnet income $1.6B
2020$13.4Bnet income $4B
2019$14.4Bnet income $5.9B
2018$13.5Bnet income $4.4B
Sources: SEC

Money

Biogen has $1M paid in by investors, lenders and donors.

$1MPaid in
$864MIncome taxes paidFY2025
$153.8MCapital expenditureFY2025
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
Loan or credit · Blackstone
Jun 2026 · Loan from Blackstone Private Credit Fund
$1MPaid
From its filingssec.gov ↗
FY2023FY2024FY2025
Income taxes paid$740.7M$355.1M$864M
Shares bought back–––
Capital expenditure$277M$153.7M$153.8M
Stock-based compensation$264.2M$291.2M$290.8M
Acquisitions, net of cash$6.9B$1.1B–
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".